SLUS:XETRA:XETRA-iShares MSCI USA ESG Screened UCITS ETF USD (Dist) (EUR)

ETF | Others |

Last Closing

USD 11.17

Change

+0.13 (+1.14)%

Market Cap

USD 0.32B

Volume

0.05M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.14 (+0.26%)

USD 445.28B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.28%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

N/A

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.06 (+0.19%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.30 (+1.20%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.14 (-0.31%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

+0.76 (+0.53%)

USD 98.84B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.15 (+0.28%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.91 (+0.85%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+6.54 (+1.06%)

USD 80.38B

ETFs Containing SLUS:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.48% 65% D 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.48% 65% D 63% D
Trailing 12 Months  
Capital Gain 32.11% 89% A- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 32.11% 89% A- 87% B+
Trailing 5 Years  
Capital Gain 103.76% 96% N/A 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 103.76% 95% A 92% A
Average Annual (5 Year Horizon)  
Capital Gain 17.45% 88% B+ 85% B
Dividend Return 17.45% 88% B+ 84% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 16.46% 29% F 41% F
Risk Adjusted Return 106.01% 92% A 93% A
Market Capitalization 0.32B 55% F 49% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.